Medical Device Contract Manufacturing Market Report 2025

This Medical Device Contract Manufacturing market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The medical device contract manufacturing market size has grown rapidly in recent years. It will grow from $101.04 billion in 2024 to $115.53 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to cost efficiency, specialized manufacturing, supply chain resilience, quality and certification, regulatory expertise.

The medical device contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $200.88 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to reshoring and nearshoring, additive manufacturing, economic and geopolitical factors, collaborative research and development (r&d), sustainable practices. Major trends in the forecast period include digital manufacturing, wearable devices, data security and privacy, material advancements, remote auditing and inspections.

The anticipated increase in chronic disorders is poised to drive the expansion of the medical device contract manufacturing market. Chronic diseases, characterized by conditions requiring continuous medical attention or activity limitations, have led to a growing demand for smart medical devices that aid patients in monitoring and managing their health conditions. This heightened demand is a key factor contributing to the growth of the medical device contract manufacturing market. As of January 2023, the National Center for Biotechnology Information (NCBI) projects a global rise in the number of individuals with chronic diseases, reaching 142.66 million by 2050 compared to 71.522 million in 2020. Therefore, the upward trend in chronic disorders is a significant driver behind the expansion of the medical device contract manufacturing market.

The increase in healthcare expenditure and government initiatives is projected to drive the growth of the medical device contract manufacturing market in the future. Pressures from healthcare spending and budget constraints create a demand for cost-effective solutions, making contract manufacturing an appealing choice. Governments frequently support local manufacturing, prioritize regulatory compliance, and provide incentives for research and development, all of which benefit contract manufacturing firms. Additionally, government initiatives encourage public-private partnerships, global market expansion, and preparedness for health emergencies, contributing to industry growth. For example, in March 2022, the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, projected that national health spending is expected to grow by an average of 5.1% annually from 2021 to 2030, ultimately reaching nearly $6.8 trillion. Furthermore, it is anticipated that Medicare spending will increase at a rate of 7.2% per year, while Medicaid spending will rise by 5.6% annually during the same period. Therefore, the rise in healthcare expenditure and government initiatives is fueling the growth of the medical device contract manufacturing market.

Major players in the medical device contract manufacturing market are strategically partnering with other firms to augment their product development initiatives. An example is the collaboration between Amnovis, a Belgium-based additive manufacturing company, and BAAT Medical, a Netherlands-based orthopedic medical devices company, announced in June 2022. This collaboration covered the entire process, from design to legal manufacturing, accelerating the time to market for 3D printed medical devices and focusing on material research, post-processing methods, process automation, and validation. The partnership aimed to set new standards for specific medical device types while streamlining the development and validation processes for medical device OEMs.

To gain a competitive edge in the market, major companies operating in the medical device contract manufacturing sector are expanding their services. In September 2022, Eakin Surgical Ltd., a UK-based medical equipment manufacturing company, announced its foray into contract manufacturing services. This expansion included services such as plastics injection molding, assembly, packaging in an ISO Class 8 cleanroom, ethylene oxide (EtO) sterilization, and sourcing hard-to-find parts for complex medical devices. This strategic move aimed to support the recovery of elective care and assist businesses in delivering high-quality, cost-effective, and reliable solutions.

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Binding Site Group for around $2.8 billion. This acquisition enhances Thermo Fisher's specialty diagnostics portfolio by incorporating innovative diagnostics and monitoring solutions for multiple myeloma. This expansion facilitates earlier diagnosis and enables more informed treatment decisions, ultimately improving patient outcomes. Thermo Fisher is committed to advancing this field further for the benefit of patients. Binding Site Group is a UK-based company that specializes in medical device contract manufacturing.

Major companies operating in the medical device contract manufacturing market include Benchmark Electronics Inc., Celestica International LP, Consort Medical plc, Flex Ltd., Gerresheimer AG, Integer Holdings Corporation, Kimball Electronics Inc., Nemera Development S.A., Nipro Corporation, Nortech Systems Inc., Phillips-Medisize Corporation, Plexus Corporation, Sanmina Corporation, Biofortuna Limited, Catalent Inc., Forefront Medical Technologies Pte Ltd., Invetech, SteriPack Group Ltd., Abbott Laboratories, Becton Dickinson and Company, Cardinal Health Inc., Danaher Corporation, GE HealthCare Technologies Inc., Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, 3M Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, Hill-Rom Holdings Inc., Masimo Corporation, ResMed Inc., Smith & Nephew plc, Teleflex Incorporated, Terumo Corporation, Zimmer Biomet Holdings Inc., Alcon Inc., Baxter International Inc., The Cooper Companies Inc., Dentsply Sirona Inc., Getinge AB, Olympus Corporation, Varian Medical Systems Inc.

North America will be the largest region in the medical device contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this medical device contract manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical device contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Medical device contract manufacturing involves a process in which a Medtech company, which owns the intellectual property, outsources the manufacturing of medical devices to another specialized manufacturing firm. This outsourcing arrangement is often chosen for benefits such as cost optimization, device upgrades, regulatory guidance, or expansion purposes.

The main types of medical devices in contract manufacturing include in vitro diagnostic (IVD) devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, ophthalmology devices, orthopedic devices, dental devices, and other devices. In vitro diagnostic (IVD) devices are medical devices used alone or in combination with other diagnostic products for in vitro use, including apparatus, equipment, or systems. The services provided by medical device contract manufacturing include device development and manufacturing services, quality management services, and assembly services. The applications of contract manufacturing services span various medical fields, including laparoscopy, pulmonary, urology, gynecology, and other applications.

The medical device contract manufacturing market research report is one of a series of new reports that provides medical device contract manufacturing market statistics, including medical device contract manufacturing industry global market size, regional shares, competitors with a medical device contract manufacturing market share, detailed medical device contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract manufacturing industry. This medical device contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The medical device contract manufacturing market includes revenues earned by entities by quality management system, ISO certified clean rooms, sterilization validation and recurring services, package design and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.